ISBioTech

@ISBioTech

The society is dedicated to the scientists and engineers who have day-to-day responsibility for creating and managing scalable and reproducible processes.

Norfolk
Vrijeme pridruživanja: svibanj 2011.

Tweetovi

Blokirali ste korisnika/cu @ISBioTech

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ISBioTech

  1. prije 10 sati

    Zhu Pirot, PhD, Director, AMD at , is slated to present “Strategy for Development of a Potency Assay for Gene Editing and Gene Therapy Products” at our . For additional speakers, visit

    Poništi
  2. proslijedio/la je Tweet

    Subscribe to our emails to stay up-to-date on the latest trends, developments, and best practices for professionals.

    Poništi
  3. 4. velj

    António M. Roldão, PhD, Head of Dev. Lab - Animal Cell Technology Unit, Health & Division at , to share “Adaptive Laboratory Evolution of Insect Cells for Improved Production of VLP-Based Vaccines” at the .

    Poništi
  4. 3. velj

    Make a plan to join us for the , March 23-25 in . Discussion topics to include expression , , and more! For info, visit

    Poništi
  5. 31. sij

    Sadik Kassim, PhD, Chief Technology Officer at , will present “Bioprocessing Opportunities for the Next Generation of Immuno-Oncology Targeted Cell Therapies” at our in .

    Poništi
  6. 30. sij

    Christopher Ballas, PhD, Sr. Vice President of Manufacturing at Innovative Cellular Therapeutics Co., Ltd. (ICT), will present “Managing Autologous CAR T-Cell Manufacturing Challenges” at March’s .

    Poništi
  7. 29. sij

    Gary W. Blissard, PhD, Professor, Insect Cell Biology at , to share “Baculovirus-Cell Interactions in the Insect Midgut: Transcriptome Profiling and Envelope Protein Trafficking” at the .

    Poništi
  8. proslijedio/la je Tweet
    29. sij

    Bioprocessing Journal is a trusted resource for up-to-date information on the latest developments and practices in the industry, available to download in an format.

    Poništi
  9. 28. sij

    Jill O. Fuss, PhD, Biophysicist Research Scientist, Molecular Biophysics and Integrated Bioimaging, Structural Biology at , to discuss the benefits of the system in cloning and production at the .

    Poništi
  10. 27. sij
    Poništi
  11. 24. sij
    Poništi
  12. 24. sij

    Matthias Hebben, PhD, VP Technology Development at , will share “Developing a Potency Assay for a Proprietary AAV-Based Genome Editing Platform Technology” at the .

    Poništi
  13. 23. sij

    Join Anil Narasimha, PhD, Co-Founder and CEO at , at the for his presentation “Automation in Delivery Technologies to Empower Breakthrough Therapies.” For event info, visit

    Poništi
  14. 22. sij

    Linda van Oosten, PhD Candidate at , will discuss the “Development of a Protein Expression System Without Baculovirus Particle Contaminants” at our in . For details, visit

    Poništi
  15. proslijedio/la je Tweet
    22. sij

    Trust our Journal to provide the latest information on best practices for industry professionals, presented in an format.

    Poništi
  16. 21. sij

    Li Zhi, Senior Scientist at , is slated to present “Assessing Purity and Structures of AAV Vector Genomes by High-Performance Size-Exclusion Chromatography” at our . For details, visit

    Poništi
  17. 20. sij
    Poništi
  18. 17. sij

    Ezequiel Zylberberg, PhD, Strategic Alliances Manager at , is slated to present “The Art of Media Optimization: Strategies for Improved Performance” at the in . For details, visit

    Poništi
  19. 16. sij

    Arifa S. Khan, PhD, Principal Investigator/Supervisor Microbiologist, Office of Vaccines Research and Review at CBER, to present “Characterization of Adventitious and Endogenous Viruses in Sf9 Cells” at the .

    Poništi
  20. 15. sij

    Debra A. Webster, PhD, Director, Advanced Therapy Medicinal Product Dev., Regulatory Sciences at , to discuss “Recent Clinical Hold Issues on Advanced Therapies and Strategies to Avoid” at March’s .

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·